Fourpath Capital Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,245
Closed -$205K 245
2025
Q1
$205K Sell
1,245
-17
-1% -$2.83K 0.04% 215
2024
Q4
$206K Sell
1,262
-1
-0.1% -$179 0.04% 218
2024
Q3
$247K Sell
1,263
-42
-3% -$7.74K 0.05% 199
2024
Q2
$226K Sell
1,305
-321
-20% -$53.4K 0.17% 119
2024
Q1
$275K Buy
1,626
+487
+43% +$91.2K 0.19% 102
2023
Q4
$225K Sell
1,139
-33
-3% -$5.84K 0.15% 115
2023
Q3
$204K Sell
1,172
-293
-20% -$53.2K 0.15% 111
2023
Q2
$252K Sell
1,465
-89
-6% -$15.4K 0.3% 80
2023
Q1
$259K Sell
1,554
-270
-15% -$44.3K 0.18% 106
2022
Q4
$267K Sell
1,824
-208
-10% -$30.8K 0.19% 101
2022
Q3
$301K Sell
2,032
-235
-10% -$39.3K 0.21% 94
2022
Q2
$390K Sell
2,267
-83
-4% -$14.4K 0.24% 88
2022
Q1
$443K Buy
2,350
+7
+0.3% +$1.38K 0.18% 96
2021
Q4
$572K Buy
+2,343
New +$513K 0.22% 79

Other funds holding ZTS

Fourpath Capital Management's ZTS Position: Q2 2025 in Review

Fourpath Capital Management sold out of Zoetis (ZTS) in Q2 2025, closing a stake of 1,245 shares — an estimated $205K sold.

Fourpath Capital Management first reported a position in ZTS in Q4 2021 and held it in 14 quarters. The position peaked at $572K in Q4 2021. 1,872 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • Fourpath Capital Management reported no remaining Zoetis position as of Q2 2025 after selling out during the quarter.
  • Fourpath Capital Management sold 1,245 Zoetis shares in Q2 2025, an estimated $205K.
  • Fourpath Capital Management first reported a position in Zoetis in Q4 2021 and held it in 14 quarters.
  • Fourpath Capital Management's Zoetis position peaked at $572K in Q4 2021.
  • 1,872 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on Fourpath Capital Management's 13F filing for Q2 2025, filed 24 Jul 2025.